Uterine Artery Embolisation Following Life-threatening Postpartum Related to Placenta Accreta

Professor J. Pelage, MD
Department of Body and Vascular Imaging, Hôpital Lariboisière, Paris, France

Patient History

  • 34-year-old female with severe vaginal haemorrhage following delivery.
  • Abnormal placentation was the cause of bleeding and failed to respond to medical treament.

Bead Block Case 8 fig 1
Pre-embolisation injection into the left uterine artery

Procedure

  • Selective injection into the left uterine artery demonstrates abnormal hypervascularisation consistent with abnormal placentation.
  • The utero-ovarian anastomosis is also seen.
  • Embolisation was achieved with Bead Block 700-900μm via a 2.8Fr Progreat™ microcatheter (large non-resorbable embolisation particles can be safely used for placenta accreta).
  • The same procedure was successfully repeated on the right side.

Outcome

  • After bilateral uterine artery embolisation, bleeding stopped immediately. No recurrence of bleeding was observed.

Clinician Comment

Large Bead Block can easily be injected through large lumen microcatheters. A very effective uterine artery occlusion can be achieved.

Professor J Pelage, MD
Hôpital Lariboisière, Paris, France

 

Bead Block Case 8 fig 2

Post-embolisation injection into the left uterine artery

Bead Block Case 8 fig 3

Pre-embolisation injection into the right uterine artery

Bead Block Case 8 fig 4

Post-embolisation injection into the right uterine artery

Regulatory notices and product safety data

Worldwide (excluding USA)

Bead Block™ is CE marked and indicated for the treatment of a variety of hypervascular tumours (including Uterine Fibroids) and arteriovenous malformations (AVMs). Bead Block™ may not be indicated for the treatment of Uterine Fibroids in your country, please check with your local distributor. For full prescribing information please refer to Bead Block instructions for use.

USA

Bead Block is intended to be used for the embolization of hypervascular tumors and arteriovenous malformations (AVMs)

Bead Block Cautions:

  • Do not use if the syringe or packaging appear damaged
  • Sterile and single use product.  Do not reuse
  • Select the size and quantity of Bead Block microspheres appropriate for the pathology to be treated
  • Embolization with Bead Block microspheres should only be performed by physicians who have received appropriate interventional occlusion training in the region intended to be embolized

For instructions for use, please refer to www.biocompatibles.com/beadblock-ifu

Bead Block Potential Complications:

  • Undesirable reflux or passage of Bead Block into normal arteries adjacent to the targeted lesion or through the lesion into other arteries or arterial beds, such as the internal carotid artery, pulmonary, or coronary circulations
  • Pulmonary embolization
  • Ischemia at an undesirable location
  • Capillary bed saturation and tissue damage
  • Ischemic stroke or ischemic infarction
  • Vessel or lesion rupture and haemorrhage
  • Neurological deficits including cranial nerve palsies
  • Vasospasm
  • Death
  • Recanalization
  • Foreign body reactions necessitating medical intervention
  • Infection necessitating medical intervention
  • Clot formation at the tip of the catheter and subsequent dislodgement